Beta Bionics (BBNX) EBT Growth (1y) (2025 - 2026)

Beta Bionics (BBNX) EBT Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -18.50%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 11.26%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -8.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -27.02%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 54.33%
10 Beta Bionics 617.66 Mn 587.36 Mn 16.44 Mn -35.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.10%
Dec 31, 2025 -11.42%
Sep 30, 2025 -39.99%
Jun 30, 2025 -56.31%
Mar 31, 2025 -94.92%